stella
beta
Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer — Stella
Recruiting
Back to Toripalimab trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Sun yat-sen University Cancer Center, Guangzhou, Guangdong
View full record on ClinicalTrials.gov